Glenda Canderan

689 citations
16 papers · 219 indexed · h-index 9
Topics
HIV Research and Treatment (5 papers)CAR-T cell therapy research (4 papers)Immune Cell Function and Interaction (4 papers)

In The Last Decade

Glenda Canderan

16 papers receiving 214 citations

Peers

Glenda Canderan
Comparison fields: 5 of 48
  • Immunology 118
  • Infectious Diseases 78
  • Virology 64
  • Molecular Biology 42
  • Oncology 34
Replace Shahzma Merani with:
Shahzma Merani United States
Antigoni Morou Canada
Laura Tarancón‐Díez Spain
Ria Goswami United States
Abigail E. Schiff United States
Shay Leary Australia
Ángel Bulnes‐Ramos Spain
Sandra Kiazyk Canada
Sharon Sen United States
Henry J. Sutton United States
Glenda Canderan relative to Shahzma Merani United States Shahzma Merani's profile →
Citations per field
00.5×1.7×
Shahzma Merani · 1×
Citations per year

Countries citing papers authored by Glenda Canderan

Since Specialization
Citations

This map shows the geographic impact of Glenda Canderan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenda Canderan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenda Canderan more than expected).

Fields of papers citing papers by Glenda Canderan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenda Canderan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenda Canderan. The network helps show where Glenda Canderan may publish in the future.

Co-authorship network of co-authors of Glenda Canderan

This figure shows the co-authorship network connecting the top 25 collaborators of Glenda Canderan. A scholar is included among the top collaborators of Glenda Canderan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenda Canderan. Glenda Canderan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 4
2 1
3 32
4 12
5 8
6 1
7 32
8 15
9 4
10 18
11 32
12 2
13 13
14 42
15 2
16 1

About Glenda Canderan

Glenda Canderan is a scholar working on Virology, Immunology and Infectious Diseases, having authored 16 papers that have together received 219 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Virology (64 citations), Immunology (118 citations) and Infectious Diseases (78 citations). Glenda Canderan has collaborated with scholars based in United States, United Kingdom and Uganda. Frequent co-authors include Rafick‐Pierre Sékaly, Lois Bayigga, Damalie Nakanjako, Rose Nabatanzi, Stephen Cose, Moses Joloba, Lydie Trautmann, Michael A. Mooney, Shannon K. McWeeney and Sarah Rowland‐Jones. Their work appears in journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026